Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.

Simůnek, T

Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone. [electronic resource] - British journal of pharmacology Sep 2008 - 138-48 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0007-1188

10.1038/bjp.2008.236 doi


Aldehydes--pharmacology
Animals
Animals, Newborn
Antibiotics, Antineoplastic--toxicity
Cell Proliferation--drug effects
Cell Survival--drug effects
Cytoprotection
Daunorubicin--toxicity
Dose-Response Relationship, Drug
HL-60 Cells
Humans
Hydrazones--pharmacology
Iron Chelating Agents--pharmacology
Leukemia, Promyelocytic, Acute--metabolism
Lipid Peroxidation--drug effects
Malondialdehyde--metabolism
Myocytes, Cardiac--drug effects
Oxidative Stress--drug effects
Rats
Rats, Wistar
Time Factors